24 July 2025
Augmentum Fintech plc
(the “Company”)
LEI: 213800OTQ44T555I8S71
Result of General Meeting
At the Company’s General Meeting held on 24 July 2025 the resolution put to
shareholders was decided by poll and was passed. The results of the poll are
set out below.
Resolutions Votes % Votes % Total Votes
For Against Votes Cast Withheld
1. (Ordinary Resolution) THAT, the appointment by Augmentum Fintech Management Limited of Augmentum Capital LLP as the Company’s investment adviser and the entry by the Company into certain agreements to facilitate such appointment, details of which are set out in the Company’s circular to Shareholders dated 1 July 2025, be approved. 69,384,998 99.4% 425,387 0.6% 69,810,385 101,318
Notes:
A vote withheld is not a vote in law and is not counted in the calculation of
the proportion of votes “For” and “Against” a resolution.
At the date of the General Meeting the total number of Ordinary shares of 1p
each in issue, excluding shares held in treasury, and the total number of
voting rights was 167,280,902.
The Circular to Shareholders dated 1 July 2025, which includes the notice of
the General Meeting and the above resolution, is available for viewing at the
National Storage Mechanism and can be located at
https://data.fca.org.uk/#/nsm/nationalstoragemechanism and on the Company’s
website, www.augmentum.vc.
In accordance with UK Listing Rule 6.4.2, a copy of the resolution will be
submitted to the National Storage Mechanism website and will shortly be
available for inspection at
https://data.fca.org.uk/#/nsm/nationalstoragemechanism.
For further information, please contact:
Frostrow Capital LLP Paul Griggs, Company Secretary +44 (0)20 3170 8733 info@frostrow.com
About Augmentum Fintech
Augmentum invests in fast growing fintech businesses that are disrupting the
financial services sector. Augmentum is the UK's only publicly listed
investment company focusing on the fintech sector in the UK and wider Europe,
having launched on the main market of the London Stock Exchange in 2018,
giving businesses access to patient capital and support, unrestricted by
conventional fund timelines and giving public markets investors access to a
largely privately held investment sector during its main period of growth.
Neither the content of any website referred to in this announcement nor the
content of any website accessible from hyperlinks is incorporated into, or
forms part of, this announcement.
Copyright (c) 2025 PR Newswire Association,LLC. All Rights Reserved